Work

Peripheral chemokine and cytokine profiles predict response and survival in recurrent ovarian cancer treated with pembrolizumab, bevacizumab and oral cyclophosphamide

Year: 2025

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.03.088

Authors: Nicole Gaulin, Suzanne Hess, Han Yu, Sarah Werner, Peter Frederick, Katherine LaVigne Mager, Karen McLean, Emese Zsiros, Luxue Deng

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414649850

FWCI:

Cites:

Cited by:

Related to: